Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease
NCT ID: NCT03348839
Last Updated: 2018-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2018-03-31
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure
NCT02082093
Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06219798
Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
NCT06257134
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
NCT03090828
Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis
NCT06024135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
NeLLY service, offering telemonitoring, educational therapy and support to patients with severe chronic kidney disease, is based on an app, both for patients and health professionals, named Ap'Telecare (@TMM).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cluster 1
NeLLY service is implemented after 8 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 2
NeLLY service is implemented after 12 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 3
NeLLY service is implemented after 16 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 4
NeLLY service is implemented after 20 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 5
NeLLY service is implemented after 24 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 6
NeLLY service is implemented after 28 months.
NeLLY service
Telesurveillance and therapeutic support
Cluster 7
NeLLY service is implemented after 32 months.
NeLLY service
Telesurveillance and therapeutic support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeLLY service
Telesurveillance and therapeutic support
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with at least 1 cardiovascular comorbidity and / or diabetes
* patient with internet connexion from home
* patient having given his express consent
Exclusion Criteria
* refusal of patient to take part in the research
* impairment of vital prognosis within a short period
* patient expecting a transplant from a living donor within 6 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Calydial
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CAILLETTE BEAUDOIN Agnès
Role: PRINCIPAL_INVESTIGATOR
Calydial
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Caen
Caen, , France
CHU Chalon
Chalon-sur-Saône, , France
CHU Clermont Ferrand
Clermont-Ferrand, , France
Centre hospitalier Saint Joseph Saint Luc
Lyon, , France
CHU Marseille
Marseille, , France
CHU Reims
Reims, , France
CHU Rennes
Rennes, , France
ARTIC 42
Saint-Etienne, , France
CHU Saint Etienne
Saint-Etienne, , France
CALYDIAL
Vienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
LOBBEDEZ Thierry
Role: primary
DUBOT Philippe
Role: primary
HENG Anne-Elisabeth
Role: primary
VILLAR Emmanuel
Role: primary
BRUNET Philippe
Role: primary
RIEU Philippe
Role: primary
VIGNEAU Cécile
Role: primary
BERTHOUX François
Role: primary
ALAMARTINE Eric
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRME-16-0418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.